EPHA1 and carcinoma: In fact, the first Eph receptor (EphA1) and the first ephrine (ephrin-A1) were both identified as tumor antigens from carcinoma cell lines [28–29], and their overexpression could lead to oncogenic transformation in NIH3T3 fibroblasts [30].